Efficacy and Safety of Inhaled Recombinant Interleukin-2 in High-Risk Renal Cell Cancer Patients Compared with Systemic Interleukin-2: an Outcome Study Cited by

Fol. Biol. 2003, 49, 183-190

https://doi.org/10.14712/fb2003049050183

Efficacy and Safety of Inhaled Recombinant Interleukin-2 in High-Risk Renal Cell Cancer Patients Compared with Systemic Interleukin-2: an Outcome Study

Edith Huland¹, A. Burger², J. Fleischer³, P. Fornara⁴, E. Hatzmann⁵, A. Heidenreich⁶, H. Heinzer¹, H. Heynemann⁴, L. Hoffmann⁷, R. Hofmann⁶, H. Huland¹, I. Kämpfer⁷, M. Kindler², H. Kirchner⁸, G. Mehlhorn⁹, T. H. Moniak⁹, U. Rebmann⁹, J. Roigas¹⁰, T. H. Schneider⁴, D. Schnorr¹⁰, H.-J. Schmitz³, R. Wenisch³, Z. Varga⁶, J. Vinke⁵

¹Department of Urology, University Hospital Hamburg-Eppendorf, Germany
²Onkologische Schwerpunktpraxis, Berlin, Germany
³St. Carolus Krankenhaus, Görlitz, Germany
⁴Martin-Luther-Universität Halle-Wittenberg, Halle, Germany
⁵Chiron BV, Amsterdam
⁶Philipps-Universität Marburg, Marburg, Germany
⁷Waldklinikum GmbH, Gera, Germany
⁸Klinikum Siloah, Germany
⁹Diakonissenkrankenhaus, Dessau, Germany
¹⁰Department of Urology, Charite, Humboldt Universität Berlin, Germany

Received October 2003
Accepted October 2003

Crossref Cited-by Linking

Posch C, Weihsengruber F, Bartsch K, Feichtenschlager V, Sanlorenzo M, Vujic I, Monshi B, Ortiz-Urda S, Rappersberger K: Low-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients. Br J Cancer 2014, 110, 1427. <https://doi.org/10.1038/bjc.2014.62>
Andrade Fernanda, Rafael Diana, Videira Mafalda, Ferreira Domingos, Sosnik Alejandro, Sarmento Bruno: Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases. Advanced Drug Delivery Reviews 2013, 65, 1816. <https://doi.org/10.1016/j.addr.2013.07.020>